课题基金 / 基金详情

DEMENTIA IN THE BLACK AGED--AD AND MID

DEMENTIA IN THE BLACK AGED--AD AND MID
黑人老年痴呆症——公元和中期
批准号:
3122058
负责人:
PHILIP B GORELICK
金额:
$33.3万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-09-01 至 1996-06-30

项目摘要

项目成果

PHILIP B GORELICK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from Applicant's Abstract) Alzheimer's disease (AD) and multi-infarct dementia (MID) are the two leading causes of progressive and irreversible dementia. Identifying risk factors associated with AD and MID is an important step in the search for etiology as well as intervention and prevention strategies. The major objective of this research application is to identify and clarify risk factors for AD and MID in an urban black aged population. Blacks have been underrepresented in biomedical, behavioral and psychosocial studies of dementia. The investigators propose to study epidemiological, medical, neuropsychological and neuroradiological characteristics by carrying out a case-control study in two groups of index cases, blacks with AD and blacks with MID, and a control group composed of blacks with multiple cerebral infarcts but without cognitive impairment. The second major objective of this project is to follow the case-control populations longitudinally to determine the rate of decline in cognitive status, to determine and compare outcome variables measuring cognitive and functional status, and mortality among black AD and MID cases with respect to descriptive history of these variables over time, and to develop hypotheses about medical and psychosocial factors that contribute to the survival disadvantage of aging black Americans. A third major objective is to accumulate enough standardized neuropathological observations on deceased cases using neuropathological criteria developed by CERAD to validate clinical diagnoses of AD and clarify valid criteria for MID in blacks. The investigators are proposing a case-control study to gather empirical data on risk factors as a prelude to the design of targeted intervention studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RISK MARKERS FOR DEMENTIA AFTER STROKE
  • 批准号:
    6088859
  • 项目类别:
  • 资助金额:
    $54.11万
  • 财政年份:
    2000
  • 负责人:
    PHILIP B GORELICK
  • 依托单位:
RISK MARKERS FOR DEMENTIA AFTER STROKE
  • 批准号:
    6594394
  • 项目类别:
  • 资助金额:
    $7.08万
  • 财政年份:
    2000
  • 负责人:
    PHILIP B GORELICK
  • 依托单位:
RISK MARKERS FOR DEMENTIA AFTER STROKE
  • 批准号:
    6509725
  • 项目类别:
  • 资助金额:
    $59.55万
  • 财政年份:
    2000
  • 负责人:
    PHILIP B GORELICK
  • 依托单位:
RISK MARKERS FOR DEMENTIA AFTER STROKE
  • 批准号:
    6629888
  • 项目类别:
  • 资助金额:
    $68.09万
  • 财政年份:
    2000
  • 负责人:
    PHILIP B GORELICK
  • 依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究